Literature DB >> 34232912

Mortality in Parenchymal and Subarachnoid Neurocysticercosis.

Jesus Abanto1,2, Daniel Blanco3, Herbert Saavedra2, Isidro Gonzales2,3, Diego Siu1, E Javier Pretell4, Javier A Bustos1,2, Hector H Garcia1,2.   

Abstract

Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. The latter, in particular subarachnoid NCC, is assumed to be more severe, but no controlled studies comparing mortality between types of NCC exist. The aim of this study was to compare all-cause mortality between patients with intraparenchymal NCC and those with subarachnoid NCC. Vital status and sociodemographic characteristics were evaluated in patients with intraparenchymal viable, intraparenchymal calcified, and subarachnoid NCC attending a neurological referral hospital in Lima, Perú. Survival analyses using Kaplan-Meier curves and Cox proportional regression models were carried out to compare mortality rates between groups. From 840 NCC patients followed by a median time of 82.3 months, 42 (5.0%) died, six (1.8%) in the intraparenchymal viable group, four (1.3%) in the calcified group, and 32 (16.6%) in the subarachnoid group (P < 0.001). Older age and lower education were significantly associated with mortality. The age-adjusted hazard ratio for death in the subarachnoid group was 13.6 (95% CI: 5.6-33.0, P < 0.001) compared with the intraparenchymal viable group and 10.7 (95% CI: 3.7-30.8, P < 0.001) when compared with the calcified group. We concluded that subarachnoid disease is associated with a much higher mortality in NCC.

Entities:  

Mesh:

Year:  2021        PMID: 34232912      PMCID: PMC8274779          DOI: 10.4269/ajtmh.20-1330

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  29 in total

1.  Neurocysticercosis: a new trend in SUDEP research?

Authors:  Fulvio Alexandre Scorza; Ricardo Mario Arida; Philipe Ribeiro Furtado de Mendonça; Esper Abrão Cavalheiro; João Pereira Leite
Journal:  Rev Soc Bras Med Trop       Date:  2012 Mar-Apr       Impact factor: 1.581

Review 2.  Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.

Authors:  Agnès Fleury; Roger Carrillo-Mezo; Ana Flisser; Edda Sciutto; Teresa Corona
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

Review 3.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

4.  Neurocysticercosis presenting as sudden death.

Authors:  J A Llompart Pou; A Gené; J I Ayestarán; C Saus
Journal:  Acta Neurochir (Wien)       Date:  2005-04-18       Impact factor: 2.216

5.  Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.

Authors:  Hector H Garcia; Andres G Lescano; Vera L Lanchote; E Javier Pretell; Isidro Gonzales; Javier A Bustos; Osvaldo M Takayanagui; Pierina S Bonato; John Horton; Herbert Saavedra; Armando E Gonzalez; Robert H Gilman
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 6.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

7.  Cysticercosis-related mortality in the State of São Paulo, Brazil, 1985-2004: a study using multiple causes of death.

Authors:  Augusto Hasiak Santo
Journal:  Cad Saude Publica       Date:  2007-12       Impact factor: 1.632

8.  A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.

Authors:  Héctor H Garcia; E Javier Pretell; Robert H Gilman; S Manuel Martinez; Lawrence H Moulton; Oscar H Del Brutto; Genaro Herrera; Carlton A W Evans; Armando E Gonzalez
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

Review 9.  Neurocysticercosis in Europe: Still a public health concern not only for imported cases.

Authors:  S Fabiani; F Bruschi
Journal:  Acta Trop       Date:  2013-07-17       Impact factor: 3.112

10.  Antiepileptic Drugs and Suicide: Role of Prior Suicidal Behavior and Parental Psychiatric Disorder.

Authors:  Julie W Dreier; Carsten B Pedersen; Christiane Gasse; Jakob Christensen
Journal:  Ann Neurol       Date:  2019-10-31       Impact factor: 10.422

View more
  1 in total

1.  A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.

Authors:  Madelynn Corda; Joshua Sciurba; Jiana Blaha; Siddhartha Mahanty; Adriana Paredes; Hector H Garcia; Theodore E Nash; Thomas B Nutman; Elise M O'Connell
Journal:  PLoS Negl Trop Dis       Date:  2022-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.